Clonidine-induced increase in osmolar clearance and free water clearance via activation of two distinct α2-adrenoceptor sites

British Journal of Pharmacology

Volumn 119, Issue 4, 1996, Pages 663-670

  Intengan, H D ^a   Smyth, D D ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Clonidine; Moxonidine; Sodium excretion; UK 14,304; Urine flow; (2a) adrenoceptor; (2b) adrenoceptor

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; BRIMONIDINE; CLONIDINE; MOXONIDINE; NALTREXONE; OPIATE ANTAGONIST; PRAZOSIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FREE WATER CLEARANCE; MALE; NONHUMAN; OSMOTIC DIURESIS; PRIORITY JOURNAL; RAT; UNINEPHRECTOMY; URINE FLOW RATE;

EID: 0029964726     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15724.x     Document Type: Article

References (22)

1. ALLAN, D.R., PENNER, S.B. & SMYTH, D.D. (1993). Renal imidazoline preferring sites and solute excretion in the rat. Br. J. Pharmacol., 108, 870 - 875.
2. BLANDFORD, D.E. & SMYTH, D.D. (1988). Dose selective dissociation of water and solute excretion after renal alpha-2 adrenoceptor stimulation. J. Pharmacol. Exp. Ther., 247, 1181 - 1186.
3. BLANDFORD, D.E. & SMYTH, D.D. (1990). Role of vasopressin in response to intrarenal infusions of alpha-2 adrenoceptor agonists. J. Pharmacol. Exp. Ther., 255, 264 - 270.
4. BLANDFORD, D.E. & SMYTH, D.D. (1991). Potentiation of the natriuretic effect of clonidine following indomethacin in the rat. Can. J. Physiol. Pharmacol., 69, 1196 - 1203.
5. BOUSQUET, P., FELDMAN, J. & SCHWARTZ, J. (1984). Central cardiovascular effects of alpha adrenergic drugs: Differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther., 230, 232 - 236.
6. BYLUND, D.B. (1985). Heterogeneity of alpha2 adrenergic receptors. Pharmacol. Biochem. Behav., 22, 835 - 843.
7. BYLUND, D.B. & RAY-PRENGER, C. (1989). Alpha-2a and alpha-2b adrenergic receptor subtypes: Attenuation of cyclic AMP production in cell lines containing only one receptor subtype. J. Pharmacol. Exp. Ther., 251, 640 - 644.
8. ERNSBERGER, P., GIULIANO, R., WILLETTE, R.N., GRANATA, A.R. & REIS, D.J. (1988). Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrenergic receptors in the rostral ventrolateral medulla. J. Hypertension, 6 (suppl. 4.), S554 - S557.
9. ERNSBERGER, P.P., DAMON, T.H., GRAFF, L.M., SCHAFER, S.G. & CHRISTEN, M.O. (1993). Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for II-imidazoline sites. J. Pharmacol. Exp. Ther., 264, 172 - 182.
10. GELLAI, M. & RUFFOLO, Jr, R.R. (1987). Renal effects of selective alpha-1 and alpha-2 adrenoceptor agonists in conscious, normotensive rats. J. Pharmacol. Exp. Ther., 240, 723 - 728.
11. HIEBLE, J.P. & RUFFOLO, Jr, R.R. (1992). Imidazoline receptors: Historical perspective. Fundam. Clin. Pharmacol., 6 (Suppl. 1), 7s - 13s.
12. MACKINNON, A.C., SPEDDING, M. & BROWN, C.M. (1994). Alpha2-adrenoceptors: More subtypes but fewer functional differences. Trends Pharmacol. Sci., 15, 119 - 123.
13. MEISTER, B., DAGERLIND, A., NICHOLAS, A.P. & HÖKFELT, T. (1994). Patterns of messenger RNA expression for adrenergic receptor subtypes in the rat kidney. J. Pharmacol. Exp. Ther., 268, 1605 - 1611.
14. NAHORSKI, S.R., BARNETTE, D.B. & CHEUNG, Y.D. (1985). Alpha-adrenoceptor effector coupling: Affinity states or heterogeneity of the alpha-2 adrenoceptor? Clin. Sci., 68, 39s - 42s.
15. PAN, L. & GUTKOWSKA, J. (1988). Is clonidine-induced diuresis mediated by atrial natriuretic factor? Endocrinology, 123, 1259 - 1263.
16. SMYTH, D.D., LI, P., BLANDFORD, D.E. & PENNER, S.B. (1992). Opposite rank order of potency for alpha-2 adrenoceptor agonists on water and solute excretion in the rat: Two sites and/or receptors? J. Pharmacol. Exp. Ther., 261, 1080 - 1086.
17. + , and water excretion. Am. J. Physiol., 252, F1016 - F1021.
18. STRANDHOY, J.W., MORRIS, M. & BUCKALEW, V. (1982). Renal effects of the antihypertensive, guanabenz, in the dog. J. Pharmacol. Exp. Ther., 221, 347 - 352.
19. TIBIRICA, E., FELDMAN, J., MERMET, C., GONON, F. & BOUSQUET, P. (1991). An imidazoline-specific mechanism for the hyportensive effect of clonidine: A study with yohimbine and idazoxan. J. Pharmacol. Exp. Ther., 256, 606 - 613.
20. UHLÉN, S. & WIKBERG, J.E.S. (1991a). Delineation of rat kidney alpha2a- and alpha2b-adrenoceptors with [3H]RX821002 radioligand binding: Computer modelling reveals that guanfacine is an alpha2a-selective compound. Eur. J. Pharmacol., 202, 235-243.
21. UHLÉN, S. & WIKBERG, J.E.S. (1991b). Delineation of three pharmacological subtypes of alpha2-adrenoceptor in the rat kidney. Br. J. Pharmacol., 104, 657-664.
22. UHLÉN, S., XIA, Y., CHHAJLANI, V., LIEN, E.J. & WIKBERG, J.E.S. (1993). Evidence for the existence of two forms of alpha2a-adrenoceptors in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 280-288.